Showing results (181-190 of 243) with videos related to

Sort By:
Pageof 25
Diabetes/Metabolism Research and Reviews|November 1, 2019
In vivo thromboxane-dependent platelet activation is persistently enhanced in subjects with impaired glucose toleranceFrancesca Santilli, Francesco Zaccardi, Rossella Liani, et al.
Atherosclerosis|January 10, 2014
Plasma autoantibodies against apolipoprotein B-100 peptide 210 in subclinical atherosclerosisOlga McLeod, Angela Silveira, Gunilla N Fredrikson, et al.
International Journal of Cardiology|November 5, 2024
Lipoproteins and lipoprotein lipid composition are associated with stages of dysglycemia and subclinical coronary atherosclerosisBruna Gigante, Qiaosen Chen, Harry Björkbacka, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|September 28, 2013
Serum 25-hydroxyvitamin D concentration in subclinical carotid atherosclerosisAnna Deleskog, Olga Piksasova, Angela Silveira, et al.
European Heart Journal. Acute Cardiovascular Care|March 31, 2026
Antithrombotic therapy for secondary prevention in patients with acute coronary syndromes treated with percutaneous coronary intervention: options for personalization to reduce bleeding or ischaemic risksDiana A Gorog, Jurrien M Ten Berg, Gianluca Campo, et al.
Atherosclerosis|January 15, 2015
Plasma IL-5 concentration and subclinical carotid atherosclerosisAngela Silveira, Olga McLeod, Rona J Strawbridge, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|June 14, 2014
Lim domain binding 2: a key driver of transendothelial migration of leukocytes and atherosclerosisMing-Mei Shang, Husain A Talukdar, Jennifer J Hofmann, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 15, 2026
Antithrombotic therapy for secondary prevention in patients with acute coronary syndromes treated with percutaneous coronary intervention: options for personalization to reduce bleeding or ischaemic risks. A Clinical Consensus Statement of the ESC Working Group on Thrombosis, the Association for Acute CardioVascular Care of the ESC, the European Association of Percutaneous Cardiovascular Interventions of the ESC, and the ESC Working Group on Cardiovascular Pharmacology A Clinical Consensus Statement of the ESC Working Group on Thrombosis, the Association for Acute CardioVascular Care of the ESC, the European Association of Percutaneous Cardiovascular Interventions of the ESC, and the ESC Working Group on Cardiovascular PharmacologyDiana A Gorog, Jurriën M Ten Berg, Gianluca Campo, et al.
The New England Journal of Medicine|December 25, 2009
Genetic variants associated with Lp(a) lipoprotein level and coronary diseaseRobert Clarke, John F Peden, Jemma C Hopewell, et al.
Biomedicines|April 3, 2021
The Association between HDL-C and Subclinical Atherosclerosis Depends on CETP Plasma Concentration: Insights from the IMPROVE StudyGualtiero I Colombo, Vanessa Bianconi, Alice Bonomi, et al.
Pageof 25